>_ QFI Terminal
TerminalStocks › XBI

State Street SPDR S&P Biotech ETF (XBI) Stock

Financial Services · Asset Management · US
$169.10 +3.00%
Last updated Aug 25, 2026 20:24 UTC

XBI Key Statistics

Market Cap$8.84B
P/E (TTM)
P/S (TTM)
P/B (TTM)
Revenue (TTM)$0.00
EPS (TTM)
Dividend Yield
ROE (TTM)
Net Margin
Gross Margin
52W High$169.68
52W Low$88.18
Analyst ViewHold
Price Target
Employees
Volume9,838,670

About State Street SPDR S&P Biotech ETF

SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.

Company website

See XBI live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open XBI in Terminal See plans

More Financial Services stocks

MUFG Mitsubishi UFJ Financial Group, Inc. HDB HDFC Bank Limited CNCK Coincheck Group N.V. BRK-B Berkshire Hathaway Inc. JPM JPMorgan Chase & Co. BAC Bank of America Corporation C Citigroup Inc. RY Royal Bank of Canada